11:08 AM EST, 03/03/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week on strong note late Monday morning, surging 1.83% higher to 1,442.61 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company Nokia ( NOK ) and biopharmaceutical company Genfit ( GNFT ) , which rose 6.3% and 6% respectively. They were followed by accommodations booking site trivago (TRVG) and financial services company ING Groep ( ING ) , which increased 5.6% and 5.3% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm Evaxion Biotech ( EVAX ) , which dropped 8.5% and 6.7% respectively. They were followed by internet browser company Opera (OPRA) and semiconductor company Sequans Communications ( SQNS ) , which were down 2% and 1.7% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Biodexa Pharmaceuticals ( BDRX ) , which advanced 6.3% and 3.7% respectively. They were followed by biopharmaceutical company TC Biopharm ( TCBP ) and mining company BHP Group ( BHP ) , which were up 3.6% and 3.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Bicycle Therapeutics ( BCYC ) , which fell 4% and 2.4% respectively. They were followed by biopharmaceutical companies NuCana ( NCNA ) and Verona Pharma ( VRNA ) , which lost 2.1% and 1.6% respectively.